Back to results
US 9,314,497 B2Granted
E2F as a target of hormone refractory prostate cancer
AssigneeRutgers, The State University of New Jersey
InventorsJoseph R. Bertino, Debabrata Banerjee, Tamara Minko, Olga B. Garbuzenko, Xiaoqi Xie, John E. Kerrigan, Emine E. Abali, Kathleen W. Scotto
Life of this patent
Estimating the term…
Abstract
The instant invention provides amino acid sequences competing with E2F for DNA binding. Methods of using said amino acid sequences for treatment of hormone-refractory prostate cancer are also provided.
Claims8
A method of treating a patient diagnosed with a blood cancer expressing E2F-1 comprising administering to the patient a peptide having an amino acid sequence consisting essentially of RQIKIWFQNRRIKWKKHHHRLSH (SEQ ID NO:
- 34).
Dependencies are inferred from the claim text.